Clinical Trial Update: BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on BreathID test for non-invasive detection of pancreatic exocrine insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Snippet

Sponsor: Meridian Bioscience, Inc. | Conditions: Chronic Pancreatitis, Healthy Volunteers | Phase 2 | Status: COMPLETED